BioRem Financial Statements From 2010 to 2024

Stocks . Canada . 
Stock . BioRem Inc
BRM Stock  CAD 3.00  0.02  0.67%   
BioRem financial statements provide useful quarterly and yearly information to potential BioRem Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioRem financial statements helps investors assess BioRem's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioRem's valuation are summarized below:
Gross Profit
6.2 M
Profit Margin
0.1135
Market Capitalization
46.5 M
Enterprise Value Revenue
1.0801
Revenue
30.9 M
There are over one hundred nineteen available fundamental signals for BioRem Inc, which can be analyzed over time and compared to other ratios. All traders should should validate BioRem's prevailing fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 9.6 M in 2024. Enterprise Value is likely to drop to about 9 M in 2024

BioRem Total Revenue

18.46 Million

Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.4 K, Total Revenue of 18.5 M or Gross Profit of 5.5 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 2.89. BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
  
This module can also supplement various BioRem Technical models . Check out the analysis of BioRem Correlation against competitors.

BioRem Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.1 M24.1 M14.4 M
Slightly volatile
Short and Long Term Debt Total2.9 M4.2 M2.6 M
Pretty Stable
Other Current Liabilities2 M2.7 M2.2 M
Slightly volatile
Total Current Liabilities7.9 M13.9 M8.6 M
Slightly volatile
Property Plant And Equipment Net2.1 M2 M719.9 K
Slightly volatile
Cash3.1 M2.3 M3.1 M
Slightly volatile
Non Current Assets Total1.9 M3.5 M1.7 M
Slightly volatile
Cash And Short Term Investments2.7 M2.3 M3.1 M
Slightly volatile
Net Receivables7.8 M15.1 M7.9 M
Slightly volatile
Common Stock Shares Outstanding22.9 M17.1 M26 M
Slightly volatile
Liabilities And Stockholders Equity15.1 M24.1 M14.4 M
Slightly volatile
Inventory764.8 K901.1 K730.2 K
Slightly volatile
Other Current Assets2.4 M2.3 M1 M
Slightly volatile
Other Stockholder Equity2.3 M2.4 M5.6 M
Slightly volatile
Total Liabilities9 M17.4 M9.8 M
Slightly volatile
Total Current Assets12.4 M20.6 M12.7 M
Slightly volatile
Short Term Debt1.2 M723.2 K1.4 M
Slightly volatile
Common Stock9.2 M5 M11.6 M
Pretty Stable
Accounts Payable3.4 M6.1 M3.1 M
Slightly volatile
Current Deferred Revenue4.5 M4.3 M2.2 M
Slightly volatile
Good Will1.1 M1.3 M1.4 M
Slightly volatile
Intangible Assets24.7 K26 K258.5 K
Slightly volatile
Non Currrent Assets Other3.8 M3.6 M1.6 M
Slightly volatile
Short and Long Term Debt520.1 K547.5 K2.2 M
Slightly volatile
Property Plant Equipment1.4 M1.3 M607 K
Slightly volatile
Long Term Debt2.8 M2.4 M2.5 M
Slightly volatile
Short Term Investments573.8 K607.2 K531.2 K
Slightly volatile
Net Invested Capital8.1 M9.7 M8.7 M
Slightly volatile
Net Working Capital5.8 M6.7 M7.1 M
Pretty Stable
Other Assets2 M1.7 M2.6 M
Slightly volatile
Capital Stock8.9 M5 M14.2 M
Slightly volatile
Property Plant And Equipment Gross5.3 M5.8 M4 M
Slightly volatile
Capital Lease Obligations869.8 K1.2 M820.9 K
Very volatile

BioRem Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization281.4 K382.7 K270.6 K
Very volatile
Total Revenue18.5 M25.2 M19.2 M
Slightly volatile
Gross Profit5.5 M6.9 M5.4 M
Slightly volatile
Other Operating Expenses18 M22.1 M18.3 M
Slightly volatile
Research Development28.9 K30.4 K323.6 K
Slightly volatile
Cost Of Revenue13.6 M18.2 M13.9 M
Slightly volatile
Total Operating Expenses5 M3.9 M4.5 M
Slightly volatile
Selling General Administrative2.4 M1.6 M2.3 M
Pretty Stable
Selling And Marketing Expenses1.9 M2.3 M2.1 M
Pretty Stable
Reconciled Depreciation271.2 K382.7 K149.6 K
Slightly volatile

BioRem Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation67 K127.7 K53.2 K
Slightly volatile
Begin Period Cash Flow2.9 M3.8 M2.9 M
Slightly volatile
Depreciation281.4 K382.7 K270.6 K
Very volatile
Capital Expenditures580.5 K552.9 K170.9 K
Slightly volatile
End Period Cash Flow3 M2.3 M3.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.590.62280.4824
Slightly volatile
Days Sales Outstanding208219151
Slightly volatile
Average Payables5.7 M5.4 M3.2 M
Slightly volatile
Stock Based Compensation To Revenue0.00530.00510.004
Slightly volatile
Capex To Depreciation1.521.44460.8288
Pretty Stable
EV To Sales0.660.6980.491
Slightly volatile
Inventory Turnover15.4220.133920.9332
Very volatile
Days Of Inventory On Hand24.3918.128620.0902
Pretty Stable
Payables Turnover3.62.95684.6303
Pretty Stable
Sales General And Administrative To Revenue0.06140.06460.119
Slightly volatile
Average Inventory503.3 K805.4 K744.3 K
Slightly volatile
Research And Ddevelopement To Revenue0.00110.00120.0216
Slightly volatile
Capex To Revenue0.01160.0220.0073
Pretty Stable
Cash Per Share0.240.14620.1805
Pretty Stable
Days Payables Outstanding10512390.7445
Pretty Stable
Intangibles To Total Assets0.00410.00430.0322
Slightly volatile
Current Ratio1.411.48291.4934
Slightly volatile
Receivables Turnover1.981.66882.6321
Slightly volatile
Graham Number1.931.15822.0196
Slightly volatile
Capex Per Share0.01890.03530.0157
Pretty Stable
Average Receivables5.1 M10.1 M6.6 M
Slightly volatile
Revenue Per Share2.571.60572.9704
Slightly volatile
Interest Debt Per Share0.20.20730.6559
Slightly volatile
Debt To Assets0.120.12360.2896
Slightly volatile
Operating Cycle137237165
Pretty Stable
Days Of Payables Outstanding10512390.7445
Pretty Stable
Ebt Per Ebit1.260.91071.0555
Pretty Stable
Long Term Debt To Capitalization0.250.26550.7858
Slightly volatile
Total Debt To Capitalization0.290.30690.7443
Slightly volatile
Quick Ratio1.351.41811.4052
Slightly volatile
Net Income Per E B T1.140.78141.7953
Slightly volatile
Cash Ratio0.160.16490.3599
Slightly volatile
Cash Conversion Cycle68.311389.2909
Very volatile
Days Of Inventory Outstanding24.3918.128620.0902
Pretty Stable
Days Of Sales Outstanding208219151
Slightly volatile
Fixed Asset Turnover12.0112.639166.0313
Pretty Stable
Debt Ratio0.120.12360.2896
Slightly volatile
Price Sales Ratio0.590.62280.4824
Slightly volatile
Asset Turnover1.01.04521.438
Slightly volatile
Gross Profit Margin0.340.2790.2852
Very volatile

BioRem Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.6 M12.3 M10.3 M
Slightly volatile
Enterprise Value9 M13.1 M9.7 M
Slightly volatile

BioRem Fundamental Market Drivers

Cash And Short Term Investments2.3 M

About BioRem Financial Statements

BioRem investors use historical fundamental indicators, such as BioRem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue4.3 M4.5 M
Total Revenue25.2 M18.5 M
Cost Of Revenue18.2 M13.6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.06  0.06 
Capex To Revenue 0.02  0.01 
Revenue Per Share 1.61  2.57 
Ebit Per Revenue 0.12  0.13 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY